At a glance
- Originator Aventis
- Class Analgesics; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 1998 No-Development-Reported for Pain in France (Unknown route)
- 29 Sep 1995 Preclinical development for Pain in France (Unknown route)